IL6 and psoriasis: In the model of IMQ-induced psoriasis-like skin disease, the prohibited IL-6 signaling pathway in myelomonocytic cells has no influence on the development and the severity of the disease, according to the clinical appearance and the number of infiltrating cells in the skin and secondary lymphoid organs.